Wyeth’s International OTC Growth Offsets Drop In U.S. Robitussin Sales

Sales of Wyeth's OTC products increased 10.4 percent worldwide in its fiscal 2008 first quarter despite a 14.2 percent drop in sales of its Robitussin cough/cold products, the firm says